Alprostadil (Prostin VR Pediatric Sterile Solution,the Upjohn Company)

Weeks JR . Prostaglandins. Annu Rev Pharmacol 1972; 12: 317.

Carlson LA Olsson AG . PGE₁ in ischemic peripheral vascular disease. In: Karim SMM , ed Practical applications of prostaglandins and their synthesis inhibitors. Lancaster, UK: MTP Press Ltd., 1979: 39–51.

Granström E . On the metabolism of prostaglandin E₁ in man. Prog Biochem Pharmacol 1967; 3: 89.

Golub M Zea P Matsuno M . Metabolism of prostaglandins A₁ and E₁ in man. J Clin Invest 1975; 56: 1404.

Neutze JM Starling MB Elliott RB . Palliation of cyanotic congenital heart disease in infancy with E-type prostaglandins. Circulation 1977; 55: 238–41.

Olley PM Coceani F Bodach E . E-type prostaglandins. A new emergency therapy for certain cyanotic congenital heart malformations. Circulation 1976; 53: 728–31.

Heymann MA Rudolph AM . Ductus arteriosus dilatation by prostaglandin E₁ in infants with pulmonary atresia. Pediatrics 1977; 59: 325–9.

Freed MD Heymann MA Lewis AB . Prostaglandin E₁ in infants with ductus arteriosus-dependent congenital heart disease. Circulation 1981; 64: 899–905.

Benson LN Olley PM Patel RG . Role of prostaglandin E₁ in the management of transposition of the great arteries. Am J Cardiol 1979; 44: 691–6.

Berman W Heymann MA Whitman V . Dilatation of the ductus arteriosus by prostaglandin E₁ in aortic arch abnormalities (abstract). Circulation 1978; 58: 44.

Christensen NC Fabricus J . Medical manipulation of the ductus arteriosus. Lancet 1975; 2: 406–7.

Coto EO Norwood WI Long P . Modified Senning operation for treatment of transposition of the great arteries. J Thorac Cardiovasc Surg 1979; 78: 721–9.

Deanfield JE . Formalin infiltration of ductus arteriosus in cyanotic congenital heart disease. Br Heart J 1981; 45: 573–6.

Donahoo JS Gardner TJ Zahka K . Systemic-pulmonary shunts in neonates and infants using microporous expanded polytetrafluoroethylene: Immediate and late results. Ann Thorac Surg 1980; 30: 146–50.

Driscoll DJ Kugler JD Nihill MR . The use of prostaglandin E₁ in a critically ill infant with transposition of the great arteries. J Pediatr 1979; 95: 259–61.

Edmunds LH Stephenson LW Godzik JP . The Blalock-Taussig anastamosis in infants younger than one week of age. Circulation 1980; 62: 597–603.

Gingell RL Pieroni DR Vlad P . Use of prostaglandin E₁ to evaluate the effect of increasing pulmonary blood flow on intracardiac mixing in patients with transposition of the great arteries. Pediatr Res 1979; 13: 444.

Gomez-Engler HE Nichols GM Sunderland C . The role of prostaglandin E₁ and valvotomy in the treatment of critical pulmonary valve obstruction with intact ventricular septum (abstract). Circulation 1979; 60: 169.

Graham TP Atwood GF Boucek RJ Jr . Pharmacologic dilatation of the ductus arteriosus with prostaglandin E₁ in infants with congenital heart disease. South Med J 1978; 71: 1238–46.

Hartmann AF Jr Hernandez A Strauss AW . The highly varied course and treatment of transposition of the great vessels (TGV) during the first year of life. Pediatr Res 1979; 13: 345.

Haworth SG Sauer U Buhlmeyer K . Effect of prostaglandin E₁ on pulmonary circulation in pulmonary atresia. Br Heart J 1980; 43: 306–14.

Henry CG Goldring D Hartmann AF Jr . Treatment of D-transposition of the great arteries: Management of hypoxemia after balloon atrial septostomy. Am J Cardiol 1981; 47: 299–306.

Henry GW Hurwitz RA Girod DA . Prostaglandin treatment of infants with cyanotic congenital heart disease. J Pediatr 1980; 96: 158.

Heymann MA Berman W Rudolph AM . Dilatation of the ductus arteriosus by prostaglandin E₁ in aortic arch abnormalities. Circulation 1979; 59: 169–73.

Ivey HH Wells HH Kattwinkel J . Prolonged use of prostaglandin E₁ to maintain patency of the ductus arteriosus in congenital heart disease (abstract). Pediatr Res 1978; 12: 384.

Kimble KJ Ariagno RL Stevenson DK . Transcutaneous oxygen monitoring, hypoxic range and correlation with prostaglandin E₁ . Clin Res 1981; 29: 142A.

Kugler JD Nihill MR McNamara DG . Association of infection and prostaglandin E₁ in infants with cyanotic congenital heart disease (abstract). Presented at the SE Pediatric Cardiology Society, Savannah, GA, 1978.

Lacina S Thilenius O Hamilton W . Congenital absence of ductus arteriosus. Circulation 1980; 62 (III): 71.

Lang P Freed MR Bierman FZ . Use of prostaglandin E₁ in infants with D-transposition of the great arteries and intact ventricular septum. Am J Cardiol 1979; 44: 76–81.

Lang P Freed MD Rosenthal A . The use of prostaglandin E₁ in an infant with interruption of the aortic arch. J Pediatr 1977; 91: 805–7.

Levitsky S van der Horst RL Hastreiter AR . Surgical palliation in aortic atresia. J Thorac Cardiovasc Surg 1980; 79: 456–61.

Lewis AB Takahashi M Lurie PR . Administration of prostaglandin E₁ in neonates with critical congenital cardiac defects. J Pediatr 1978; 93: 481–5.

Lewis AB Freed MD Heymann MA . Side effects of therapy with prostaglandin E₁ in infants with critical congenital heart disease. Circulation 1981; 64: 893–8.

Linday LA Engle MA . Prostaglandin treatment of newborns with ductal-dependent congenital heart disease. Pediatr Ann 1981; 10: 29–38.

Linday L Levin AR Reitman M . Prostaglandin E₁ infusion. Successful initial treatment. NY State J Med 1981; 81: 218–21.

Miyamoto K Zavanella C Lewin AN . Aorta-pulmonary artery shunts with expanded polytetrafluoroethylene (PTFE) tube. Ann Thorac Surg 1979; 27: 413–7.

Mocellin R Sauer U Schumacher G . Einfluss von Prostaglandin E₁ auf die Haemodynamik bei Neugeborenen mit Pulmonalatresie (includes English summary). Z Kardiol 1978; 67: 572–7.

Momma K Takao A Shinohara T . Ductus arteriosus dilatation by PGE₁ in cyanotic congenital heart disease. Jpn Circ J 1978; 42: 743.

Moreno F Burqueros M Herraiz I . Perfusion con prostaglandinas (PGE) en neonatos con cardiopatie severa (includes English summary). Rev Esp Cardiol 1978; 31: 335–8.

Moulaert A Gittenberger-DeGroot A Harinck E . Effects de la prostaglandine dans les malformations cardiaques avec canal arteriel obligatoire. Etude clinique et histologique (includes English summary). Arch Fr Pediatr 1978; 35: 717–25.

Needleman H Dick M Crowley D . D-transposition of the great arteries (DTGA) associated with syndrome of persistence of fetal circulation (PFC). Pediatr Res 1979; 13: 349.

Olley PM Coceani F Rowe RD . Role of prostaglandin E₁ and E₂ in the management of neonatal heart disease. Adv Prostaglandin Thromboxane Res 1978; 4: 345–53.

Park I Nihill MN Titus JL . Morphologic features of the ductus arteriosus after PGE₁ administration for ductus dependent congenital heart diseases. Am J Cardiol 1981; 47: 447.

Pitlick P French JW Maze A . Long-term low-dose prostaglandin E₁ administration. J Pediatr 1980; 96: 318–20.

Roland JMA Kan JS Kidd L . Prostaglandin E₁ infusion for ductus dependent cardiac lesions (abstract). Pediatr Res 1978; 12: 389.

Sankaran K Conly J Boyle CAJ . Intestinal colic and diarrhea as side effects of intravenous alprostadil administration. Am J Dis Child 1981; 135: 664–5.

Schleman MM Casta A Mongkolsmai C . Prostaglandin E₁ in the neonate with heart disease. Adv Prostaglandin Thromboxane Res 1980; 7: 879–81.

Schober JG Kellner M Christian I . Prostaglandin E₁: Wirkung auf die Blutgase bei zyanotischen Neugeborenen (includes English summary). Klin Paediatr 1977; 189: 365–9.

Schober JG Kellner M Mocellin R . Indications and pharmacological effects of therapy with prostaglandin E₁ in the newborn. Adv Prostaglandin Thromboxane Res 1980; 7: 905–11.

Schumacher G Mocellin R Schober JG . Hamodynamische und angiokardiographische Befunde bei Neugeborenen mit zyanotischen Herzsfehlern und verminderter Lungendurchblutung unter der Therapie mit Prostaglandin E₁ (includes English summary). Klin Paediatr 1978; 190: 465–73.

Sone K Tashiro M Fujinaga T . Long-term low-dose prostaglandin E₁ administration. J Pediatr 1980; 97: 866–7.

Starling MB Neutze J Elliott RB . Effect of prostaglandins and some methyl derivatives on the ductus arteriosus. Adv Prostaglandin Thromboxane Res 1978; 4: 335–43.

Strauss AW Kumar S Henry C . Prostaglandin E₁ (PGE₁) and the ductus arteriosus (DA). Pediatr Res 1979; 13: 352.

Synhorst D Matlak M Road Y . Separation of conjoined thoracopagous twins joined at the right atria. Am J Cardiol 1979; 43: 662–5.

Ueda K Saito A Nakano H . Cortical hyperostosis following long-term administration of prostaglandin E₁ in infants with cyanotic congenital heart disease. J Pediatr 1980; 97: 834–6.

van der Horst R Hastreiter AR Levitsky S . Interrupted aortic arch operation in the first week of life: Hemodynamic and angiographic evaluation one year later. Ann Thorac Surg 1979; 27: 112–20.

Weir EK Matisonn RE Losman E . Prostaglandin E₁ in infants with pulmonary atresia. S Afr Med J 1978; 54: 700–2.

Williams RG Bierman FZ . Evaluation of balloon atrial septostomy by subxiphoid two dimensional echocardiography. Am J Cardiol 1979; 43: 401.

Yabek SM Mann JS . Prostaglandin E₁ infusion in the hypoplastic left heart syndrome. Chest 1979; 76: 330–1.

Zahka KG Roland JMA Cutilletta AF . Management of aortic arch interruption with prostaglandin E₁ infusion and microporous expanded polytetrafluoroethylene grafts. Am J Cardiol 1980; 46: 1001–5.

Noah ML . Use of prostaglandin E₁ for maintaining the patency of the ductus arteriosus. Adv Prostaglandins Thromboxane Res 1978; 4: 355–62.

Norwood WI Kirklin JK Sanders SP . Hypoplastic left heart syndrome: Experience with palliative surgery. Am J Cardiol 1980; 45: 87–91.

Freedom RM Olley PM Coceani F . The prostaglandin challenge. Test to unmask obstructed total anomalous pulmonary venous connections in asplenia syndrome. Br Heart J 1978; 40: 91–4.

Lewis AB Lurie PR . Prolonged prostaglandin E₁ infusion in an infant with cyanotic congenital heart disease. Pediatrics 1978; 61: 534–6.

Cole RB Abman S Aziz KU . Prolonged prostaglandin E₁ infusion: Histologic effects on the patent ductus arteriosus. Pediatrics 1981; 67: 816–9.

Gittenberger-DeGroot AC Moulaert AJ Harinck E . Histopathology of the ductus arteriosus after prostaglandin E₁ administration in ductus dependent cardiac anomalies. Br Heart J 1978; 40: 215–20.

Raflo GT Wangensteen SL Gleen SL . Mechanism of the protective effects of prostaglandins E₁ and F2α in canine endotoxin shock. Eur J Pharmacol 1973; 24: 86–95.

Jugdutt BI . Prostaglandins in myocardial infarction: With emphasis on myocardial preservation. Prostaglandins Med 1981; 7: 109–23.

Carlson LA Olsson AG . Intravenous prostaglandin E₁ in severe peripheral vascular disease. Lancet 1976; 2: 810.

Sham B Messerly AM . Apnea in the premature infant. Nurs Clin North Am 1978; 13: 29–37.

Fariello R Olley PM Coceani F . Neurological and electroencephalographic changes in newborns treated with prostaglandins E₁ and E₂ . Prostaglandins 1977; 13: 901–7.

Dekel S Francis MJO . Cortical hyperostosis after administration of prostaglandin E (letter). J Pediatr 1981; 99: 500–1.

Package insert. Prostin VR Pediatric. The Upjohn Co., Kalamazoo, MI, 1981.